Get started
Author

Eva González‐Iglesias

Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity
2023 · Pablo Zubiaur, Paula Soria‐Chacartegui, et al. · Clinical Pharmacology & Therapeutics · 15
PDF
Next-Generation Sequencing Screening of 43 Families with Non-Syndromic Early-Onset High Myopia: A Clinical and Genetic Study
2022 · Eva González-Iglesias, Ana López-Vázquez, et al. · International Journal of Molecular Sciences · 12
PDF
Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics
2024 · Eva González-Iglesias, Dolores Ochoa, et al. · Frontiers in Pharmacology · 6
Whole-Exome Sequencing of 21 Families: Candidate Genes for Early-Onset High Myopia
2023 · Eloísa Sánchez-Cazorla, Carmen González-Atienza, et al. · International Journal of Molecular Sciences · 6
PDF
Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers
2024 · Andrea Rodríguez-Lopez, María Martínez-Sendino, et al. · Biomedicines · 5
PDF
Effect of Genetic Variants on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Involvement of ABCG2, SLCO1B1 and NAT2
2024 · Eva González-Iglesias, Clara Méndez-Ponce, et al. · International Journal of Molecular Sciences · 4
PDF
Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride
2023 · Gonzalo Villapalos-García, Pablo Zubiaur, et al. · Journal of Personalized Medicine · 4
PDF
Impact of Sex and Genetic Variation in Relevant Pharmacogenes on the Pharmacokinetics and Safety of Valsartan, Olmesartan and Hydrochlorothiazide
2023 · Paula Soria-Chacartegui, Pablo Zubiaur, et al. · International Journal of Molecular Sciences · 4
PDF
The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review
2025 · Eva González-Iglesias, Jesús Novalbos, et al. · Pharmacogenomics · 3
Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter
2025 · Eva González-Iglesias, Dolores Ochoa, et al. · Biomedicine & Pharmacotherapy · 2
Genetic Variation in CYP2D6, UGT1A4, SLC6A2 and SLCO1B1 Alters the Pharmacokinetics and Safety of Mirabegron
2024 · Paula Soria-Chacartegui, Patricia Cendoya-Ramiro, et al. · Pharmaceutics · 2
Update on the PriME-PGx initiative: evolution of pharmacogenetics in daily clinical practice
2024 · Eva González-Iglesias, Francisco Abad-Santos · Pharmacogenomics · 2
PDF
Estrogens prevent the hypothalamus-periphery crosstalk induced by olanzapine intraperitoneal treatment in female mice: Effects on brown/beige adipose tissues and liver
2024 · Vítor Ferreira, Cintia Folgueira, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2
Genetic variation in UGT1A1 is not associated with altered liver biochemical parameters in healthy volunteers participating in bioequivalence trials
2024 · Eva González-Iglesias, Dolores Ochoa, et al. · Frontiers in Pharmacology · 2
PDF
An Investigational Study on the Role of CYP2D6, CYP3A4 and UGTs Genetic Variation on Fesoterodine Pharmacokinetics in Young Healthy Volunteers
2024 · Andrea Rodríguez-Lopez, Dolores Ochoa, et al. · Pharmaceuticals · 1
PDF
SLCO1B1 and ABCG2 genotype‐informed phenotypes are related to variation in ramipril exposure
2024 · Houwaida Abbes, Pablo Zubiaur, et al. · Basic & Clinical Pharmacology & Toxicology · 1
Genomic and Sex Contributions to Interindividual Variability in Pitavastatin Bioavailability
2026 · Eva González‐Iglesias, Sofía Moreno‐Pérez de Villar, et al. · Basic & Clinical Pharmacology & Toxicology
Corrigendum to “Apixaban kinetics could be influenced by sex, cytochrome P450 enzymes and SLC6A2 transporter” [Biomed. Pharmacother. 193 (December) (2025) 118732]
2025 · Eva González-Iglesias, Dolores Ochoa, et al. · Biomedicine & Pharmacotherapy
Design of an Array to Evaluate Biomarkers of Response to Biological Treatments in Inflammatory Bowel Disease
2025 · Andrea Rodríguez-Lopez, Eva González-Iglesias, et al. · Future Pharmacology
PDF
Works count: 19
Citation count: 71
H-index: 5
I10-index: 2
Year
Topic
Type